Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-15-007334)

Filing Details

Accession Number:: 0000899243-15-007334
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-10-30 16:05:27
Reporting Period:: 2015-10-29

Filing Date:: 2015-10-30
Accepted Time:: 2015-10-30 16:05:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1559053	Prothena Corp Plc	PRTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242880	S Christopher Henney	C/O Prothena Biosciences Inc 650 Gateway Boulevard South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value $0.01 Per Share	Acquisiton	2015-10-29	5,000	$6.65	5,000	No	4	M	Direct
Ordinary Shares, Par Value $0.01 Per Share	Disposition	2015-10-29	5,000	$55.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (right to buy)	Disposition	2015-10-29	5,000	$0.00	5,000	$6.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
35,000		2023-03-18	No	4	M	Direct

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
The shares subject to the option are fully vested and exercisable as of the date hereof.